Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol and Remifentanil for Neurocognitive Recovery in Older Patients After Surgery
NCT07479719Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Apr 2026
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of propofol injection (veterinary), remifentanil in Post-operative cognitive dysfunction (POCD), sponsored by Peking University First Hospital. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
propofol injection (veterinary)remifentanil
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT07479719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07479719.